John K. Clarke - May 21, 2021 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role: Director
Signature: Nancy Denyes, Attorney-in-Fact
Stock symbol: LIFE
Transactions as of: May 21, 2021
Transactions value $: -$10,850
Form type: 4
Date filed: 5/25/2021, 09:05 PM
Next filing: Apr 28, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LIFE	Common Stock	Sale	-$10.9K	-2.5K	-2.26%	$4.34	108K	May 21, 2021	See Footnote	F1, F2
holding	LIFE	Common Stock						7.49K	May 21, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These shares were sold to cover fund expenses.
F2	These shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These shares were sold to cover fund expenses.

These shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose.